Related by context. All words. (Click for frequent words.) 71 intraobserver 69 Sensitivity specificity 68 CIN2 + 68 F FDG PET 68 interobserver 68 interobserver reliability 68 urine cytology 68 serum PSA 67 interobserver agreement 67 confidence intervals CIs 67 SUVmax 67 HER2 expression 67 pCR 67 PSA nadir 67 cytologic 67 statistical significance p 66 cTnI 66 HOMA IR 66 PSADT 66 Cronbach alpha 66 intraclass correlation coefficient 65 intact parathyroid hormone 65 coronary stenosis 65 myocardial viability 65 FDG-PET/CT 65 prognostic indicators 65 multivariate Cox 65 ASCUS 65 AST ALT 64 pulmonary angiography 64 pretest probability 64 reaction RT PCR 64 metabolite concentrations 64 quantitative reverse transcriptase 64 immunohistochemical analysis 64 albumin excretion 64 EUS FNA 64 creatinine ratio 64 PCR assay 64 Interrater reliability 64 erythrocyte sedimentation rate 64 FDG uptake 64 intraclass correlation coefficients 64 interrater reliability 64 multivariable analysis 64 eosinophil count 64 biochemical recurrence 63 serum biomarkers 63 urine albumin 63 echocardiographic parameters 63 univariate 63 platelet reactivity 63 FDG PET 63 plain radiographs 63 RT PCR assay 63 helical CT 63 TRUS 63 lactate dehydrogenase 63 convergent validity 63 Flow cytometry 63 electrophysiologic 63 thyroglobulin 63 leukocyte count 63 clinicopathological features 63 ultrasonographic 63 bronchoalveolar lavage 63 chi squared 63 PITX2 methylation 63 #F FDG PET 63 conditional logistic regression 63 SpCO 63 Pearson correlation coefficient 63 lymph node metastasis 63 Cystatin C 63 transient elastography 63 Histologic 63 D dimer 63 Cardiorespiratory fitness 63 FDG PET CT 63 immunohistochemical 63 lymphocyte count 63 cardiac troponin T 63 Prognostic 63 preoperative PSA 62 cardiac perfusion 62 APTIMA HPV 62 SCr 62 MMSE score 62 procalcitonin 62 Kaplan Meier analysis 62 D Dimer 62 XIENCE V PROMUS Stent 62 antibody titer 62 tumor perfusion 62 Viral load 62 anti JCV antibodies 62 Descriptive statistics 62 cystoscopic 62 dosimetric 62 scintigraphic 62 adenoma detection 62 myocardial necrosis 62 myocardial perfusion 62 quantitative PCR 62 thickness IMT 62 regression coefficients 62 liver histology 62 % Confidence Interval 62 tPSA 62 p# antigen 62 semiquantitative 62 glycosylated hemoglobin HbA1c 62 mIU ml 62 HER2 overexpression 62 Prostate specific antigen 62 morphometric vertebral fractures 62 specific antigen PSA 62 radiotherapy RT 62 intima media thickness 62 urinary N telopeptide 62 proton MR spectroscopy 62 induced sputum 62 SLNB 62 prognostic significance 62 glomerular filtration 62 qRT PCR 62 Pharmacokinetic parameters 62 serum cortisol 62 neutrophil counts 62 immunohistochemistry IHC 62 tumor histology 62 quantitative gene expression 62 Hemoccult II 62 complete cytogenetic response 62 log# copies mL 61 plasma cortisol 61 PSA kinetics 61 busulfan 61 transabdominal 61 multivariable logistic regression 61 microbiological eradication 61 Intermountain Risk Score 61 eNO 61 secondary efficacy endpoint 61 histologic subtype 61 EBUS FNA 61 eTag assays 61 reaction PCR 61 tissue oxygenation 61 K ras mutations 61 oncologic outcomes 61 predictive validity 61 logistic regression analyzes 61 pmol L 61 etiologic 61 cTnT 61 arterial oxygen saturation 61 Crohn Disease Activity 61 histopathological 61 tracer uptake 61 immunohistochemical staining 61 pT3 61 immunostaining 61 exhaled nitric oxide 61 multiple logistic regression 61 troponin T 61 NPM1 mutation 61 preoperative diagnosis 61 pT2 61 bone scintigraphy 61 nonparametric 61 arthrography 61 postoperative complication 61 #.#ng/ml 61 T SPOT.TB 61 immunochemical 61 quantitation 61 guaiac 61 interrater 61 transcranial Doppler 61 aspartate aminotransferase 61 chest radiographs 61 sustained virological response 61 neutrophil count 61 Coronary CTA 61 multivariable adjusted 61 BACcel ™ system 61 Non inferiority 61 EGFR mutation status 61 carotid IMT 61 serum PTH 61 microvessel density 61 glomerular filtration rate 61 apparent diffusion coefficient 61 transthoracic 61 KRAS mutation 61 Logistic regression 61 Score IPSS 61 locoregional recurrence 61 CSF biomarkers 61 advanced neoplasia 61 antigen PSA levels 61 HRCT 61 p = #.# [003] 61 retest reliability 61 PCWP 61 chemosensitivity 61 malignant nodules 61 ARB telmisartan 61 HBsAg 61 μmol L 61 conventional coronary angiography 61 hemoglobin Hb 61 colonoscopic 61 Prognostic Value 61 urodynamic 61 Bonferroni 61 Index CDAI 61 RQ PCR 61 serologic 61 hsCRP levels 61 multivariate analyzes 61 ± #.#mm [001] 61 Doppler sonography 61 nested PCR 61 univariate analysis 60 genotypic resistance 60 OGTT 60 serum HBV DNA 60 posttreatment 60 lymphovascular invasion 60 viral kinetics 60 RT qPCR 60 mammographically 60 ADCS CGIC 60 d dimer 60 MDRD 60 serum prostate 60 carcinoembryonic antigen 60 serum aminotransferase levels 60 clinico pathological 60 odds ratios ORs 60 logistic regression analysis 60 spirometric 60 p# biomarker 60 AUCs 60 FDG PET imaging 60 HCV antibody 60 ertapenem 60 coronary CTA 60 logistic regression 60 fluorescence intensity 60 baseline LDH 60 biodistribution 60 methylation markers 60 polyp detection 60 miRview squamous 60 CD# expression [001] 60 Reproducibility 60 intravesical therapy 60 neurologic progression 60 pharmacodynamic markers 60 postoperative radiotherapy 60 malignant lesions 60 pharmacodynamic PD 60 Histopathologic 60 contrast echocardiography 60 carotid stenosis 60 gadolinium enhanced 60 multidetector row 60 AGHD 60 Cervista HPV HR 60 histopathologic 60 prostate cancer CaP 60 Multivariate logistic regression 60 creatinine levels 60 definite stent thrombosis 60 alanine aminotransferase ALT 60 ELISpot 60 interpretability 60 plasma renin activity 60 colonography 60 ^ sup #m 60 radical prostatectomy RP 60 quantitative polymerase chain 60 iPTH 60 multiplexing capability 60 HIV tropism 60 histological subtype 60 QT QTc 60 transfection efficiency 60 florbetaben 60 NMIBC 60 serum concentrations 60 arterial elasticity 60 ischemic lesions 60 dose Iluvien 60 postoperative mortality 60 Kaplan Meier 60 calculated creatinine clearance 60 plasma pharmacokinetics 60 reproducible measurements 60 isoprostane 60 hematological parameters 60 Genotypic 60 protein excretion 60 response CCyR 60 F FDG uptake 60 co receptor tropism 60 mL/min/#.# m 2 60 lactate dehydrogenase LDH 60 NIHSS score 60 T2 lesions 60 underwent surgical resection 60 alanine aminotransferase 60 EQ 5D 60 seminal vesicle invasion 60 AUA Symptom Score 60 HBeAg 60 HbA 1C 60 vivo potency 60 Univariate 60 inotropic 60 serum bilirubin 60 COHb 60 elevated transaminases 60 seropositivity 60 mg BID dose 59 Immunohistochemistry IHC 59 pharmacodynamic parameters 59 NMP# 59 Linear regression 59 conventional angiography 59 cystatin C 59 waist circumference WC 59 % CI #.#-#.# [005] 59 clinicopathological 59 serum thyroglobulin 59 microsatellite instability 59 reverse transcription polymerase 59 computed tomographic 59 Repeatability 59 nomogram 59 multivariable Cox 59 chemiluminescence 59 hc2 59 albumin excretion rate 59 glycated hemoglobin HbA1c 59 Radical prostatectomy 59 thyrotropin levels 59 colorectal adenoma 59 albumin creatinine ratio 59 International Prostate Symptom 59 carotid artery thickness 59 SELDI TOF MS 59 virological response 59 reagent consumption 59 CIN3 59 PASI scores 59 antitumor effect 59 viral titers 59 glycated hemoglobin levels 59 homocysteine concentrations 59 metabolic parameters 59 abnormal cytology 59 Hb A1C 59 electron beam computed tomography 59 CCyR 59 corrected QT interval 59 Preoperative 59 LC MALDI 59 obstructive coronary artery 59 Wilcoxon rank sum 59 peak VO2 59 molecular biomarkers 59 CK MB 59 LDL HDL 59 cellularity 59 ImmuKnow 59 VerifyNow 59 prostate carcinoma 59 QTc prolongation 59 detecting colorectal cancer 59 adnexal mass 59 Multivariate analysis 59 urothelial carcinoma 59 nomograms 59 gauge vitrectomy 59 Prostate Specific Antigen 59 Kaplan Meier survival 59 WOMAC pain 59 Sensitivity analyzes 59 transvaginal sonography 59 aminotransferases 59 Kruskal Wallis test 59 stent stenosis 59 histologic findings 59 Doppler echocardiography 59 elevated ALT 59 transgene expression 59 TNSS 59 SGPT 59 bronchial hyperresponsiveness 59 fluorodeoxyglucose positron emission tomography 59 thyroid stimulating hormone 59 Y BOCS 59 axillary lymph node 59 perfusion imaging 59 Breslow thickness 59 clinically localized prostate 59 miRview mets 59 kidney allograft 59 Predictive Value 59 χ 59 atheroma volume 59 extracolonic findings 59 estimated GFR 59 adenoma recurrence 59 #S rRNA gene 59 expiratory flow 59 treat NNT 59 foveal thickness 59 TRAIL R1 59 troponins 59 assay ELISA 59 serum albumin 59 pleural fluid 59 response pCR 59 biochemical relapse 59 -#.# log# copies mL 59 Western blotting 59 EpCAM expression 59 MDCTA 59 posttest 59 differential gene expression 59 rheumatoid factor 59 Response Evaluation Criteria 59 CDAI score 59 cardiac troponin 59 virologic response 59 viral tropism 59 mass spectrometric 59 dyssynchrony 59 multiple linear regression 59 NIST traceable 59 histologic 59 Secondary efficacy endpoints 59 maternal serum 59 pretreatment serum 59 antiangiogenic agent 59 Poisson regression 59 ALT elevation 59 ELISA assays 59 #OHD 59 correlation coefficients 59 residual platelet reactivity 59 Cervista HPV 59 serum biomarker 59 multiplex PCR 59 CR nPR 59 MR spectroscopy 59 TURBT 59 reliabilities 59 prespecified secondary 59 generalized estimating 59 CHADS2 59 DCE MRI 59 grade squamous intraepithelial 59 sonographic findings 59 TOF PET 59 posttransplant 59 advanced adenomas 59 Severity MSCS score 59 undetectable HBV DNA 59 multivariate logistic regression 59 micrometastasis 59 Randomized clinical trials 59 hip BMD 59 CP CPPS 59 CYP#D# genotype 59 tirofiban 59 fundus photography 58 ROC curves 58 logistic regression model 58 Echocardiographic 58 reproducibility 58 HbA 1c levels 58 T2 weighted 58 thickness CIMT 58 TIMP 1 58 prognostic indicator 58 logistic regression models 58 HbA1C 58 epithelial tumors 58 TMPRSS2 ERG 58 intravascular ultrasonography 58 PROLARIS 58 Hemoglobin A1c 58 transcranial Doppler ultrasound 58 ELISPOT 58 unpaired t 58 permanently discontinue Vectibix 58 apolipoproteins 58 surface plasmon resonance SPR 58 prostate cancer PCa 58 histopathologic findings 58 prognostic markers 58 lymphocytosis 58 ptau 58 RECIST Response Evaluation Criteria 58 diffusion tensor 58 ROC curve 58 VKORC1 58 Bioavailability 58 perioperative morbidity 58 SLN biopsy 58 MDRD equation 58 N glycan 58 nucleotide substitutions 58 Annexin V 58 serum markers 58 Supplementary Table 58 PD2i ® 58 Liver biopsy 58 RRM1 58 Mantel Haenszel 58 Haptoglobin 58 advanced adenoma 58 gadolinium enhancing lesions 58 TLUS 58 picogram 58 plasma kallikrein inhibitor 58 nanomolar 58 serum lipid 58 antiviral efficacy 58 LC-MS/MS 58 diagnostic modality 58 pulmonary capillary wedge 58 immunochemical fecal occult 58 reactive hyperemia 58 mCi 58 serum calcium 58 cytokeratin 58 spectrophotometric 58 virologic responses 58 diagnosing coronary artery 58 mediated dilation 58 hemodynamic variables 58 κ 58 amaZon 58 lumbar spine BMD 58 urine dipstick 58 #ng/ml 58 PCR assays 58 urinary albumin 58 chromatograms 58 plasma creatinine 58 biopsy Gleason 58 dose proportionality 58 mean ± SEM 58 liquid chromatography tandem 58 univariate analyzes 58 adnexal masses 58 pg ml 58 Bonferroni correction 58 angiographically 58 bovine thrombin 58 KRAS status 58 LV ejection fraction 58 haematologic 58 binary logistic regression 58 tumorigenicity 58 central corneal thickness 58 cardiac biomarkers 58 bivariate analysis 58 Platelet counts 58 mammographic density 58 serum antibody 58 Elastography 58 Glomerular filtration rate 58 rebleeding 58 Quantitation 58 nodal metastases 58 serum potassium 58 cytologic examination 58 PITX2 58 LVNC 58 microalbumin 58 sonographically guided 58 STRIDE PD 58 attenuation correction 58 antibiotic susceptibility 58 neutrophil gelatinase associated lipocalin 58 DAS# CRP 58 postoperative morbidity 58 antigen PSA 58 predictive biomarker 58 recursive partitioning 58 confirmed CCyR 58 Angiographic 58 ug ml 58 qualitative serum 58 transrectal ultrasound guided 58 differentially expressed proteins 58 ADAS Cog 58 Immunohistochemical staining 58 EBMT criteria 58 Pharmacodynamic 58 dose atorvastatin 58 proteomic analysis 58 deCODE BreastCancer TM 58 SensoLyte ™ 58 binary restenosis 58 femtogram 58 microRNA profiling 58 ETDRS 58 μg L 58 serum estradiol 58 operable breast cancer 58 immunoreactivity 58 NADiA TM 58 MAGE A3 ASCI 58 % CI #.#-#.# [003] 58 Enzyme Linked Immunosorbent Assay 58 Histopathological 58 renal artery stenosis 58 extracapsular extension 58 VerifyNow P#Y# 58 lupus anticoagulant 58 Qmax 58 P = .# 58 colorimetric 58 pathologic diagnosis 58 PCA3 gene 58 spiral computed tomography 58 myeloperoxidase 58 lymphadenectomy 58 needle aspiration 58 Insulin sensitivity 58 Rating Scale BPRS 58 differentiate squamous 58 #Gy 58 immunofluorescent 58 colorectal neoplasms 58 covariance ANCOVA 58 BACcel ™ 58 monoclonal gammopathy 58 linkage disequilibrium 58 genotypic 58 estrogen receptor ER 58 aspartate aminotransferase AST 58 TPMT 58 coronary arteriography 58 variant allele 58 mIU mL 58 enteroviral 58 Visual Analogue Scale VAS 58 Corus CAD 58 invasive coronary angiography 58 immunoblot 58 electrocardiographic 58 obstructive CAD 58 Symptom severity 58 myocardial infarct size 58 Fine needle aspiration 58 fractional anisotropy 58 troponin assay 58 Gram stain 58 IgG antibody 58 QTcF 58 Skin sterol 58 NATRECOR ® 58 hepatorenal syndrome 58 serum BDNF 58 Capacity FVC 58 Troponin T 58 Preoperatively 58 pharmacodynamic profiles 58 SiMoA 58 HGPIN 58 Ejection Fraction 58 radiographic findings 58 IDI MRSA 58 Ki# 58 multivariable analyzes 58 -#.# ± [002] 57 neostigmine 57 pharmacodynamic biomarkers 57 #.#/#.# mmHg [001] 57 -#.# log# 57 p tau 57 hormone receptor status 57 radioimmunoassay 57 gene amplification 57 rho = 57 squamous intraepithelial lesions 57 endoscopic ultrasonography 57 biopsy specimens 57 Primary endpoints 57 metastatic lymph nodes 57 erection hardness 57 Sanger sequencing 57 coronary stenoses 57 ug mL 57 nerve conduction velocity 57 mU L 57 cyclic voltammetry 57 allele frequencies 57 CR CRu 57 HBeAg seroconversion 57 FFR measurements 57 distant metastasis 57 sDNA 57 Secondary endpoints included 57 Western Blotting 57 serum testosterone 57 aldosterone antagonist 57 progression TTP 57 COR Analyzer 57 BRCA2 mutation carriers 57 Mean Symptom Complex 57 IL#B 57 pulsed Doppler 57 cTnT levels 57 CIN3 + 57 Histological 57 vincristine doxorubicin 57 #q# deletion 57 DIGE 57 mg kg Hematide 57 sustained virologic response 57 pharmacokinetic equivalence 57 KRAS mutations occur 57 Subgroup analysis 57 allelic 57 relapsed MM 57 HDRS 57 Recurrence Score 57 SpO 2 57 prospectively defined 57 cCTA 57 Ultrasonography 57 % CI #.#-#.# [001] 57 hemoglobin hematocrit 57 tolerability pharmacokinetics 57 prognostic biomarker 57 OnDose TM 57 bivalirudin monotherapy 57 oxygen saturation SpO2 57 multiplex assay 57 salivary flow 57 grade cervical intraepithelial 57 KRAS mutations 57 ELISA enzyme 57 conventional cytology 57 myocardial reperfusion 57 ratio ICER 57 #q# deletion syndrome 57 renal artery stenting 57 VerifyNow P#Y# Test 57 FENO 57 guaiac test 57 hepatic enzymes 57 parasitological 57 bi ventricular pacing 57 cerebral oxygen saturation 57 symptomatic intracranial hemorrhage 57 invasive aspergillosis 57 serum lipid levels 57 creatine kinase MB 57 aggregated Abeta 57 abacavir lamivudine 57 neurocognitive function 57 angiographic restenosis 57 PCR amplification 57 inter rater reliability 57 B7 H3 57 nicardipine 57 pharmacokinetic characteristics 57 gemcitabine carboplatin 57 nonselective NSAIDs 57 Brief Psychiatric 57 renal biopsy 57 symptomatic VTE 57 Kaplan Meier method 57 variance ANOVA 57 Multiple logistic regression 57 circular dichroism 57 serum ferritin 57 angiography CTA 57 electrospray ionisation 57 percutaneous vertebroplasty 57 DAS# scores 57 Lp PLA 2 57 HER2 amplification 57 anogenital distance 57 radiation dosimetry 57 Oncotype 57 transrectal ultrasound 57 MADRS score 57 glycosylated hemoglobin levels 57 Alkaline Phosphatase 57 pharmacodynamic effects 57 serum IgE 57 CC genotype 57 lumbar disk herniation 57 Adenomas 57 p = .# [002] 57 DLQI 57 endometrial biopsy 57 left ventricular diastolic 57 Fractional Flow Reserve 57 debulking surgery 57 histopathologic examination 57 invasive carcinomas 57 neoplasias 57 microbiologically evaluable 57 F FDG 57 nasal symptom 57 Computed tomographic 57 prognostic 57 stratifying patients 57 hematopoietic cancers 57 NSCLC tumors 57 quantitative coronary angiography 57 sputum cytology 57 SGRQ 57 resected pancreatic cancer 57 Secondary endpoints include 57 IOP lowering 57 endocrine therapies 57 non dispersive infrared 57 Coronary CT angiography 57 carcinomatosis 57 creatinine clearance 57 activated partial thromboplastin 57 spectroscopic technique 57 cEVR 57 MR arthrography 57 Ishak fibrosis score 57 postprocedure 57 enzyme inhibition 57 urolithiasis 57 PCa 57 CTEPH 57 hepatic fibrosis 57 intravascular hemolysis 57 cytoreductive surgery 57 Arch Intern Med 57 prognostic variables 57 Specificity 57 R0 resection 57 hemostatic efficacy 57 N telopeptide 57 locoregional 57 hemodynamically significant 57 CA9 SCAN 57 Hazard Ratio HR 57 Eur J Endocrinol 57 lateral radiographs 57 Immunohistochemical 57 Cardiotoxicity 57 regression coefficient 57 -#.# mg dL [001] 57 radiographic outcomes 57 ELISAs 57 KRAS mutation status 57 Subgroup analyzes 57 endometrial thickness 57 analgesic efficacy 57 Solorel TM 57 heap leach recoveries 57 Serologic 57 reverse transcriptase polymerase chain 57 periprocedural MI 57 anti JCV antibody 57 Computed tomography 57 percutaneous biopsy 57 histologic examination 57 bronchoalveolar lavage BAL 57 NGAL 57 pelvic ultrasound 57 ovarian malignancy 57 genomewide 57 estimated glomerular filtration 57 familial aggregation 57 C Reactive Protein 57 apolipoprotein B 57 non squamous histology 57 hematologic parameters 57 hippocampal atrophy 57 Fibromyalgia Impact Questionnaire 57 myocardial revascularization 57 hypogonadal 57 APACHE II 57 Pearson correlation coefficients 57 Mass Spectrometry MS 57 ALT elevations 57 pulp metallic 57 bronchopulmonary dysplasia BPD 57 Bulk density 57 #mg dose [002] 57 PreDx DRS 57 Glomerular Filtration Rate 57 RNFL thickness 57 tHcy 57 HbA 1c 57 cecal intubation 57 SPECT CT imaging 57 BENICAR HCT 57 inflammatory biomarkers 57 BRAF V#E mutation 57 Injury Severity Score 57 densitometry 57 poor metabolizers 57 miRview ™ squamous 57 pulmonary arterial 57 atrioventricular block 57 Renal Cell Carcinoma RCC 57 renal cortical 57 serum urate levels 57 fetal aneuploidy 57 HIV coinfected 57 RNFL 57 epistasis 57 #dhTxB# 57 bioelectrical impedance 57 echocardiographic 57 assay detects 57 NT proBNP 57 EuroSCORE 57 psychiatric comorbidity 57 perioperative mortality 57 liver metastasis 57 phenotypic expression 57 EBUS 57 postintervention 57 peginterferon alpha 57 unfractionated heparin UFH 57 methacholine challenge 57 ^ Tc 57 thyroid carcinoma 57 tryptase 57 ACR Pedi 57 fluorescence detection 57 exhaled NO 57 FT IR spectroscopy 57 antiangiogenic activity 57 coronary computed tomography 57 BPH Symptom Score 57 Prostate Cancer Progression 57 prostatic adenocarcinoma 57 myocardial function 57 quantitative PCR qPCR 57 parasitaemia 57 HbA1C levels 57 sCJD 57 HIV HCV coinfected 57 p = NS 57 skin sterol 57 Amplicor 57 electrocardiography ECG 57 biochemical markers 57 clinically meaningful improvement 57 CSF Tf 57 ACI TIPI 56 LightLab OCT 56 eosinophilia 56 sacral neuromodulation 56 Outpatient Setting 56 photon detection 56 galiximab 56 corneal thickness 56 histological diagnosis 56 nucleoside naive patients 56 catheter angiography 56 pharmacodynamic properties 56 β blockers 56 uL 56 Virologic 56 ERalpha 56 multiplexed assays 56 -#.# mg dL [002] 56 nonfasting triglyceride levels 56 hypericin 56 prospectively randomized 56 = #.#-#.# 56 ALT AST 56 covariance 56 Serum creatinine 56 PET myocardial perfusion 56 tipranavir r 56 HER2 ErbB2 56 Kinoid 56 arteriography 56 IV bisphosphonates 56 preintervention 56 PD2i 56 ExTRACT TIMI